Screener
Rigel Pharmaceuticals RIGL Product sales, net — Revenue recognized
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Rigel Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001034842-26-000032
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Revenues: | ||
| Product sales, net | $54,923 | $43,550 |
| Contract revenues from collaborations | 3,895 | 9,783 |
| Total revenues | 58,818 | 53,333 |
| Costs and expenses: | ||
| Cost of product sales | 4,606 | 4,409 |
| Research and development | 11,676 | 8,436 |
| Selling, general and administrative | 30,651 | 27,715 |
Item 1. Financial Statements
FAQ
- What is Rigel Pharmaceuticals's product sales, net — revenue recognized?
- Rigel Pharmaceuticals (RIGL) reported product sales, net — revenue recognized of $54.92M in Q1 2026.
- How has Rigel Pharmaceuticals's product sales, net — revenue recognized changed year-over-year?
- Rigel Pharmaceuticals's product sales, net — revenue recognized increased by 26.1% year-over-year, from $43.55M to $54.92M.
- What is the long-term trend for Rigel Pharmaceuticals's product sales, net — revenue recognized?
- Over 4 years (2021 to 2025), Rigel Pharmaceuticals's product sales, net — revenue recognized has grown at a 38.5% compound annual growth rate (CAGR), from $63.01M to $231.98M.
- What does product sales, net — revenue recognized mean?
- This metric represents the total revenue generated from the direct sale of pharmaceutical products after accounting for variable considerations such as rebates, discounts, returns, and allowances. It serves as a primary indicator of commercial adoption and market demand for the company's proprietary therapeutic portfolio. Tracking this figure allows investors to evaluate the underlying growth trajectory and revenue-generating capacity of the company's core commercialized assets.
Ask your AI about Rigel Pharmaceuticals's product sales, net — revenue recognized.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude